Status:
COMPLETED
Caffein Consumption and Response Inhibition
Lead Sponsor:
Uppsala University
Conditions:
Eating Behavior
Obesity
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
With the abundance of energy-dense foods that are designed for ease of consumption in the current environment, it is of importance to better understand the factors that may undermine the control of en...
Detailed Description
In a blinded, randomized cross-over design, participants will receive either a capsule with caffeine or placebo at two separate occasions whereupon study tasks will be performed.
Eligibility Criteria
Inclusion
- Only males
- 18 ≤ 35 years
- Healthy (self rated)
- Used to drink caffeine
- Used to eat breakfast regularly (≥ 5 times a week).
- Non-smokers
Exclusion
- BMI outside the range of 18,5 ≤ 25
- hypersensitivity for the ingredients of the foods under study
- being a vegan or vegetarian. Participants reported not using products that are artificially sweetened, nor sugar in coffee and/or tea
- Presence of any chronically disease and/or treatment with medication
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01815203
Start Date
March 1 2013
End Date
August 1 2013
Last Update
September 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uppsala University
Uppsala, Sweden, 75319